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ABSTRACT
Background: GJA1 gene encodes a gap junction protein known as connexin 43 (Cx43). Cx43 is abundantly 
expressed in the ventricular myocardium and in cardiac neural crest cells. Cx43 is proposed to play an important 
role in human congenital heart disease, as GJA1 knock-out mice die neonatally from outflow tract obstruction. 
In addition, patients with visceroatrial heterotaxia or hypoplastic left heart syndrome were reported to have 
point mutations in GJA1 at residues that affect protein kinase phosphorylation and gating of the gap junction 
channel. However, as these clinical findings were not replicated in subsequent studies, the question remains about 
the contribution of GJA1 mutations in human congenital heart disease (CHD). Materials and Methods: We 
analyzed the GJA1 coding sequence in 300 patients with CHD from two clinical centers, focusing on outflow tract 
anomalies. This included 152 with Tetralogy of Fallot from over 200 patients exhibiting outflow tract anomalies, 
as well as other structural heart defects including atrioventricular septal defects and other valvar anomalies. Our 
sequencing analysis revealed only two silent nucleotide substitutions in 8 patients. To further assess the possible 
role of Cx43 in CHD, we also generated two knock-in mouse models with point mutations at serine residues 
subject to protein kinase C or casein kinase phosphorylation, sites that are known to regulate gating and trafficking 
of Cx43, respectively. Results: Both heterozygous and homozygous knock-in mice were long term viable and 
did not exhibit overt CHD. Conclusion: The combined clinical and knock-in mouse mutant studies indicate 
GJA1 mutation is not likely a major contributor to CHD, especially those involving outflow tract anomalies.
Key words: Connexin43, congenital heart disease, gap junction, knock-in mouse model, outflow tract, 
phosphorylations
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INTRODUCTION
The gene GJA1 encodes a gap junction protein known 
as connexin 43 (Cx43). Cx43 is abundantly expressed in 
the ventricular myocardium, where it plays an important 
role in electrical conduction in the heart.[1,2] Cx43 is also 
proposed to play a role in congenital heart disease (CHD), 
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as GJA1 knock-out mice die neonatally from outflow 
tract obstruction associated with conotruncal heart 
malformation. These malformations consist of pouches 
positioned at the base of the pulmonary outflow tract, 
a region known as the infundibulum. These pouches are 
comprised of elaborate intraventricular trabeculations 
forming lacunae and sinusoidal cavities that cause 
pulmonary outflow obstruction, with neonatal lethality 
resulting from failure to establish normal pulmonary 
circulation.[3] These mice also show various coronary artery 
anomalies[4] associated with dysregulation of coronary 
vasculogenesis.[5] Previous studies had shown that Cx43 
plays an important role in modulating the migratory 
behavior of cardiac neural crest cells (CNC), and the 
resulting defects in the deployment of CNCs[6] underlies 
the conotruncal heart malformation.[7] Other studies in 
chick, Xenopus and mice suggest that the precise regulation 
of Cx43 function may be critical in other developmental 
processes as well.[8-13]
A possible role for GJA1 in CHD has been suggested by 
the report of GJA1 point mutations in a clinical study   
of patients with visceroatrial heterotaxia and hypoplastic 
heart syndrome. Six patients with visceroatrial heterotaxia[14] 
and eight patients with hypoplastic left heart syndrome 
(HLHS)[15] exhibited mutations involving serine and 
threonine residues that affect protein kinase phosphorylation 
and gating of the gap junction channel. However, as these 
findings were not replicated in subsequent clinical studies, 
the question remains about the contribution of GJA1 
mutations in human CHD.[16-20]
To further investigate the role of GJA1 mutations in 
CHD in this study, we screened for GJA1 mutations by 
direct sequencing the coding region of Deoxyribonucleic 
acid (DNA) obtained from 300 patients with CHD, 
over 200 of which have outflow tract anomalies. We 
also generated two mouse models to directly address 
the role of Cx43 phosphorylation in CHD with the 
targeted knock-in of Cx43 point mutations at serine 
residues subject to protein kinase C (PKC) or casein 
kinase 1 (CK1) phosphorylation. We chose to investigate 
these particular amino acid residues given previous 
studies showing that they can modulate gap junction 
conductance and/or trafficking of the Cx43 protein, 
respectively.[21-23] Both mouse models were found to 
be viable and fertile, and with no obvious decrease in 
viability or long term lifespan. The combined results from 
the mouse and human studies do not support a major 
role for GJA1 mutations in human CHD, especially those 
involving the outflow tract.
MATERIALS AND METHODS
Patient recruitment
Patients were recruited with protocols approved by the 
Institutional Review Board (IRB) at The Children’s Hospital 
of Philadelphia (CHOP), and the Fudan University 
Children’s Hospital in China (FUCH). Cardiovascular 
diagnoses were confirmed by an attending pediatric 
cardiologist, who reviewed echocardiograms and/or 
echocardiogram reports, cardiac catheterization reports, 
and operative notes if applicable.
Deoxyribonucleic acid extraction, polymerase chain 
reaction amplification, and DNA sequencing
For FUCH patients, deoxyribonucleic acid (DNA) was 
obtained from peripheral blood in all subjects. DNA 
from patients at CHOP was prepared from blood or 
lymphoblastoid cell lines. Genomic DNA was extracted 
using standard techniques. The coding region of GJA1 
was polymerase chain reaction (PCR) amplified using 
primers designed to exclude the GJA1 pseudogene 
in the human genome[24] [Figure 1a and Table 1]. At 
FUCH, each DNA sample was subjected to two rounds 
of nested PCR. In the first round, the whole coding 
region was amplified using F1 and R3 primers followed 
by amplification of three overlapping fragments using 
combination of all 6 pair of primers [Table 1]. At CHOP 
the whole coding region was amplified using two sets of 
overlapping primers [Table 1]. At both centres, 25-40 
cycles of amplification was carried out by hot start DNA 
polymerase using annealing temperature of 58-60oC The 
resulting product was sequenced by Sanger sequencing 
using standard protocols.
Gja1 Knock-in mouse models
Targeting constructs with Gja1, point mutations were 
made with floxed neomycin selection cassette and either 
PGK-Neo (S368A) or PGK-Neo-Stop (S330A, S328Y, 
and S325A) and a thymidine kinase negative selection 
cassette [Figure 1b]. After electroporation, ES cells were 
screened with long range PCR using primers amplifying 
from the homology arms to the floxed neomycin cassette 
[Table 2], and homologous recombination was confirmed 
by Southern blotting [Figure 2]. PCR amplifications were 
carried out with Advantage 2 polymerase (clonetech) with 
initial annealing temp going down by 0.5oC per cycle 
starting from 64oC for 20 cycles followed by annealing 
at 52oC for next 18 cycles.208 Journal of Cardiovascular Disease Research Vol. 2 / No 4
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Figure 1:  Genomic deoxyribonucleic acid (DNA) amplification and targeting construct design (a) GJA1 genomic DNA amplification and sequencing. 
The location of primers used for polymerase chain reaction (PCR) amplification and sequencing of the coding region of GJA1 (black region) are 
indicated. Primers were designed to avoid amplification of the pseudogene.[26] (b) Gja1 knock-in construct design  The knock-in vectors contained 
floxed PGK-Neo (S368A) or PGK-Neo-Stop (S330A/S328Y/S325A), a thymidine kinase cassette, and 5’/3’ homology arms (dashed lines). Mutation 
in the mouse Gja1 knock-in constructs (vertical arrow) consisted of S368A (AGC->GCT) or S330A:S328Y:S325A (TCC->GCA;TCC->TAC;AGC-
>GCA). Primers used for screening are described in Table 4.
Table 1: Primers for polymerase chain reaction amplification of patient deoxyribose nucleic Acid†
Primer sequence Polymerase chain reaction product
F1:GAAATACGTGAAACCGTTGG R3:CCTGGTGCACTTTCTACAGC 1348bp
F1:GAAATACGTGAAACCGTTGG R1:TCTTGTTCAGTTTCTCTTCCTTTC 451bp
F2:TATTTGTGTCTGTACCCACACTCTTGT R2:CCTTAACCCGATCCTTAACGC 477bp
F3:GTGTCCCTGGCCTTGAATAT R3:CCTGGTGCACTTTCTACAGC 568bp
Fa:AGAATGTTAGAAATACGTGAAACC Ra: TTCCCTTAACCCGATCCTTA 862 bp
Fb: GCTGCGAACCTACATCATCAGTAT Rb: AAGGCTGTTGAGTACCAC 810 bp
†F1-F3 and R1-R3: primers were used at FUCH; Fa-Fb and Ra-Rb: Primers were used at CHOP.
Table 2: Primers for screening knock-in mice
  Primer sequences Polymerase chain reaction product
5HF:GCAAGATCCTGTGCTGAAAAACC 5HR:CTCGACTGTGCCTTCTAGTTGC 2.6kb
3HF:ACTGCCTTGGGAAAAGCGCCTC 3HR:AACCGCCTGTTCTGATGCTCTC 5.9kb
LPF:CTCACAGCTCTAATCCTCCTCCCTC LPR:CTGACAGGCTCTACCTACCAAGTGC WT: 461bp
KI –Neo: 550bp
KI +Neo: >2kb
MF:ACTCTCACCTATGTCTCCTCCT MR:CCCTACTTTTGCCGCCTAGCTA 519bp209 Journal of Cardiovascular Disease Research Vol. 2 / No 4
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Figure 2:  Southern blot analysis of Cx43 KI mice. (a) On the top shown is the representation of the genomic region of Cx43 gene with positions 
of diagnostic restriction site. Below shown is the representation of Cx43 KI construct and position of diagnostic restriction site. Also shown is the 
position of primers that was used for genotyping the mice. (b) Southern blot of genomic DNA digested with either PstI (left panel) or XbaI (right 
panel) and hybridized with e 5’ and 3’ probe respectively. The position of the probe was shown on map of panel A. Pst I digested genomic DNA 
hybridized to with 5’ probe (left panel) should produce 8.0 Kb fragment for wildtype (lane 5) and 4.6 Kb fragment for KI mice (lane 1-4). Xba I 
digested genomic DNA hybridized to with 3’ probe (right panel) should produce 9.5 Kb fragment for wildtype (lane 5) and 8.7 Kb fragment for KI 
mice (lane 1-4).
a
b
Table 3: Congenital heart defects in patient cohorts
Outflow tract defects Valvar defects Other defects
Tetralogy of fallot (152) ‡ Aortic atresia (3) Coarctation of aorta (7)
Pulmonary atresia (6) Tricuspid atresia (9) Visceroatrial heterotaxy (11)
Truncus arteriosus (6) Mitral atresia (3) Single atrium (3)
Transposition of great arteries (31) Atrio-ventricular septal defect (22) Single ventricle (5)
Double-outlet right ventricle (29) Interrupted aortic arch (1)
Hypoplastic right heart syndrome (4)
Total/Partial anomalous pulmonary venous drainage (4)
Hypoplastic left heart syndrome (4)
‡ Number in parenthesis equal to number of patients recruited in the study
Immunoblotting and immunohistochemsitry
Western immunoblotting was performed as previously 
described and quantified using a Li-Cor Biosciences 
Odyssey infrared imaging system and associated software 
(inverted images are presented).[23] Cx43 was detected 
with our Cx43NT1 antibody[25] and the antibody against 
vinculin was obtained from Sigma Chemical Co. (V4505). 
Immunohistochemistry was performed on formalin-fixed 
paraffin sections of hearts from wild-type, CK1 and 
S368A mice. Briefly, the de-paraffinized and hydrated 
histologic sections were subjected to heat-induced 
epitope retrieval for 20 minutes, blocked with 5% normal 
goat serum and 1% Bovine Serum Albumin (BSA) in 
phosphate buffered saline (PBS) for 30 minutes, and then 
incubated with rabbit anti-Cx43 antibody (1:500) for 1 210 Journal of Cardiovascular Disease Research Vol. 2 / No 4
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hour at room temperature.[26] Sections were washed in 
PBS and incubated with Alexa fluor 647 goat anti-rabbit 
secondary antibody (Invitrogen) for 30 minutes. Sections 
were washed three times and then were embedded in 
Prolong Gold Antifade reagent (Invitrogen). Fluorescence 
images were acquired using a TissueFax-System 
(TissueGnostics, Vienna, Austria) with far-red (Cy5, 
HyQ filter set: Excitation 590-650, emission 673-762) 
Zeiss PlanApo 20X/OD objective. After thresholding, 
the number of pixels in junctions (i.e., area) and intensity 
of the pixels were quantified using the public domain 
National Institutes of Health (NIH) Image program 
(developed at the United States National Institutes of 
Health and available on the Internet at http://rsb.info.
nih.gov/nih-image/).
RESULTS
Sequencing for GJA1 mutations in patients with 
congenital heart disease
We analyzed 300 patients with CHD recruited at FUCH and 
CHOP, including 224 patients with outflow tract anomalies, 
152 of which had tetralogy of Fallot (TOF) that included 
the full range of pulmonary valve morphologies (stenosis, 
atresia, “absent”) [Table 3]. Approximately 50% of the 
patients from both cohorts were less than 1 year of age 
[Table 4]. Double stranded DNA sequencing showed no 
amino acid altering mutations in these 300 patients. Two 
novel synonymous nucleotide substitutions were found in 
several TOF patients: G717A in one patient from FUCH, 
and C555T (1 patient) and G717A (6 patients) from the 
CHOP cohort. As GJA1 mutations were suggested to 
arise de novo in somatic tissues in patients with CHD,[15] 
we also analyzed genomic DNA from surgically resected 
right ventricular outflow tract myocardium for 26 of the 
patients from FUCH; however, no difference in the DNA 
sequence was found.
Gja1 knockin mouse mutants show no overt 
congenital heart defects
Given limitation in the patient sample size, we made 
two Gja1 knock-in constructs to assess whether specific 
Gja1 mutations at important regulatory sites in Cx43 
can cause CHD in mice. These included a construct 
[Figure 1b] containing S368A substitution at a PKC 
phosphorylation site in Cx43 that reduces channel 
conductance,[21] and a construct with S325A/S328Y/
S330A (CK1) mutations at sites phosphorylated by 
casein kinase 1 known to regulate Cx43 assembly into 
a gap junction structure.[22,23] From previous work, we 
know that elimination of S368 or S325/328/330 would 
change the conductance properties of the resulting 
gap junction channels.[22,27-29] Mice from both knock-in 
constructs were heterozygous/homozygous viable [Figure 
3; data not shown], with apparently normal lifespan (mice 
could be routinely aged > 12 months) and no obvious 
CHD. Surprisingly, immunostaining of mutant mice 
Table 4: Patients with complex heart defects from Children’s Hospital of Philadelphia (CHOP) and Fudan University 
Children’s Hospital in China (FUCH)
Fudan University Children’s Hospital in China
Gender Age
< 28D 28D < 1Y 1Y < 3Y >3Y 
Male 14 cases 51 cases 17 cases 33 cases
Female 6 cases 20 cases 18 cases 23 cases
% each age period 11.0% 39.0% 19.2% 30.8%
Figure 3:  Genotype distribution of Gja1 knock-in mice litters. Shown 
are the genotype distribution recovered in three litters of mice 
obtained from the mating of heterozygous Gja1 knock-in mice with the 
S330A:S328Y:S325A (CK1) mutation. The genotype obtained (blue) is 
not significantly different from the expected distribution (red). 
Children’s Hospital of Philadelphia
Gender Age
< 28D 28D < 1Y 1Y < 3Y >3Y  Unknown
Male 2 cases 18 cases 4 cases 8 cases 1 case
Female 1 case 7 cases 4 cases 9 cases 0 Case
% each age period 5.60% 46.3% 14.8% 31.5% 1.80 %211 Journal of Cardiovascular Disease Research Vol. 2 / No 4
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Table 5: Reduction of Cx43 expression in Cx43 knock-in mice
Cx43 Vinculin Cx43/Vanculin
Lane 1 WT (1) 99.99 129.04 0.774876007
Lane 2 WT (2) 83 105.55 0.786357177
Lane 3 CK1 (1) 76.81 136.78 0.561558707
Lane 4 CK1 (2) 98.61 178.6 0.55212766
Lane 5 PKC (1) 41.67 144.88 0.287617338
Lane 6 PKC (2) 32.69 128.32 0.254753741
Where, WT = Wild type-Cx43; PKC = protein kinase C; CK1 = Casein kinase 1 
DISCUSSION
We found no amino acid altering mutations in GJA1 gene in 
300 patients with CHD, including 224 patients with outflow 
tract anomalies. However, two synonymous sequence 
variants were found - one is a novel Single Nucleotide 
Polymorphism [SNP (C555T)] and another is a known 
variant in National Center for Biotechnology Information 
(NCBI) Single Nucleotide Polymorphism database [dbSNP 
(G717A, rs57946868)]. Given the neonatal lethality of the 
Gja1 knockout mouse, it is possible that the disruption or 
perturbation of the Cx43 function may not be postnatal 
viable. We note that in both cohorts, half of the patients 
with complex CHD were less than 1 year of age.
Mutations in GJA1 have been reported in patients with 
oculodentodigital dysplasia (ODDD),[31] a disorder causing 
craniofacial and limb dysmorphisms, neurodegeneration 
and deafness. Cardiac abnormalities were rare and 
consisted of conduction anomalies, with one ODDD 
individual exhibiting ventricular tachycardia and atrio-
ventricular block associated with a Ile130Thr mutation, 
and another with atrioseptal defects associated with a 
Gly21Arg mutation. We noted a mutant mouse model 
with a N-ethyl-N-nitrosourea-induced point mutation in 
Gja1G60S exhibited phenotypes similar to ODDD.[32] Also 
Figure 4: Cx43 localization in heart tissue from wildtype, S368A and 
S235A/S328Y/S330A mice. Paraffin-embedded sections of mouse 
hearts were stained with Cx43 primary and secondary as indicated in 
the Materials and Methods. 4’,6-diamidino-2-phenylindole (DAPI) was 
used to stain nuclei (bar = 500µm). The lower row of panels shows 
higher magnification views of the indicated portions from the panels 
above (bar = 60 µm)
Figure 5: Characterization of total Cx43 in mouse hearts. Western blots 
of whole heart lysates, isolated from two WT (Wild type-Cx43), CK1 
(S325A/S328Y/S330A) or two PKC (S368A) hearts, simultaneously 
probed for total Cx43. Membranes were also probed with anti-vinculin 
antibody, as an internal loading control. Notice that Cx43 protein levels 
are decreased in CK1 and PKC mice compared with WT. Positions of 
the molecular weight markers are shown on the left
showed no significant difference in Cx43 localization gap 
junctions; and, the density of Cx43 immunostaining did 
not appear to be significantly changed when compared 
to wildtype hearts [Figure 4]. The integrated densities 
of the area of junctional staining in arbitrary units were:   
Wild type-Cx43 (WT) = 18742±5191; CK1 = 17957±3851; 
PKC = 17352±1415.
When heart tissue was analyzed by Western immunoblotting, 
we observed the typical reduced sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) migration 
of Cx43 due to its phosphorylation at sites such as 
S325/328/330 in the wild type mouse tissues,[23] that was 
much less prominent in heart tissue from the CK1 mice 
[Figure 5]. We had previously shown that phosphorylation 
at S368 does not affect SDS-PAGE migration.[30] The 
PKC1 mice, however, also showed a loss of these 
slower migrating species. Quantitation of the Western 
blot showed the Cx43 protein expression level (when 
normalized to vinculin) was reduced by more than 70% in 
the PKC mutant and nearly 30% in the CK1 mutant mouse 
hearts [Table 5]. Although, these mice could potentially 
show altered responses to acute signaling events, we did 
not detect any developmental defects or changes in their 
long-term viability or lifespan.212 Journal of Cardiovascular Disease Research Vol. 2 / No 4
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in these patients, there were no structural heart defects 
except for some cases of patent foramen ovale.
Surprisingly, our studies showed Gja1 knock-in mice with 
point mutations at important regulatory serine residues 
Gja1S368A or Gja1S325A/S328Y/S330A were homozygous, viable 
and fertile. We chose to examine the S328Y mutation since 
early findings indicated that this site might be modified in 
a CHD patient,[14,15] although subsequent studies indicated 
this was not the case.[16-20] Findings from the previous in 
vitro studies would have predicted that these mice should 
show functional impairment for Gja1 due to defects in Cx43 
trafficking and or gating of the Cx43 gap junction channel. 
These unexpected findings show the importance of animal 
model studies to validate in vitro findings.[21,22] Together, 
our results indicate that GJA1 mutations are not commonly 
associated with outflow tract anomalies. These findings do 
not preclude a role for GJA1 mutations in a more complex 
or severe CHD condition associated with prenatal/neonatal 
lethality, a clinical population difficult to survey.
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